Abstract:Through their multiple targets, microRNAs (miRNAs) are involved in numerous physiological and pathological processes. In this study, miR‐342‐3p was found to be deregulated with ossification of ligament or osteoporosis. We demonstrate that silencing miR‐342‐3p impairs osteoblast activity and matrix mineralization, while over expression of miR‐342‐3p promotes osteoblast differentiation significantly. Moreover, miR‐342‐3p directly targets activating transcription factor 3 (ATF3), which inhibits transcription of p… Show more
“…In the current study, we suggest that a miRNA is an upstream regulator of ATF3. Indeed, an alternate miRNA, miR-342-3p , targets ATF3 to promote osteogenic differentiation of human mesenchymal stem cells, 67 which implicates the existence of a diverse miRNA-ATF3 network. In this study, we did not address which upstream signals affect the decrease in the expression of miR-27a-3p .…”
Vascular calcification, the ectopic deposition of calcium in blood vessels, develops in association with various metabolic diseases and atherosclerosis and is an independent predictor of morbidity and mortality associated with these diseases. Herein, we report that reduction of
microRNA-27a-3p
(
miR-27a-3p
) causes an increase in activating transcription factor 3 (ATF3), a novel osteogenic transcription factor, in vascular smooth muscle cells. Both microRNA (miRNA) and mRNA microarrays were performed with rat vascular smooth muscle cells, and reciprocally regulated pairs of miRNA and mRNA were selected after bioinformatics analysis. Inorganic phosphate significantly reduced the expression of
miR-27a-3p
in A10 cells. The transcript level was also reduced in vitamin D
3
-administered mouse aortas.
miR-27a-3p mimic
reduced calcium deposition, whereas
miR-27a-3p inhibitor
increased it. The Atf3 mRNA level was upregulated in a cellular vascular calcification model, and
miR-27a-3p
reduced the
Atf3
mRNA and protein levels. Transfection with
Atf3
could recover the
miR-27a-3p
-induced reduction of calcium deposition. Our results suggest that reduction of
miR-27a-3p
may contribute to the development of vascular calcification by de-repression of ATF3.
“…In the current study, we suggest that a miRNA is an upstream regulator of ATF3. Indeed, an alternate miRNA, miR-342-3p , targets ATF3 to promote osteogenic differentiation of human mesenchymal stem cells, 67 which implicates the existence of a diverse miRNA-ATF3 network. In this study, we did not address which upstream signals affect the decrease in the expression of miR-27a-3p .…”
Vascular calcification, the ectopic deposition of calcium in blood vessels, develops in association with various metabolic diseases and atherosclerosis and is an independent predictor of morbidity and mortality associated with these diseases. Herein, we report that reduction of
microRNA-27a-3p
(
miR-27a-3p
) causes an increase in activating transcription factor 3 (ATF3), a novel osteogenic transcription factor, in vascular smooth muscle cells. Both microRNA (miRNA) and mRNA microarrays were performed with rat vascular smooth muscle cells, and reciprocally regulated pairs of miRNA and mRNA were selected after bioinformatics analysis. Inorganic phosphate significantly reduced the expression of
miR-27a-3p
in A10 cells. The transcript level was also reduced in vitamin D
3
-administered mouse aortas.
miR-27a-3p mimic
reduced calcium deposition, whereas
miR-27a-3p inhibitor
increased it. The Atf3 mRNA level was upregulated in a cellular vascular calcification model, and
miR-27a-3p
reduced the
Atf3
mRNA and protein levels. Transfection with
Atf3
could recover the
miR-27a-3p
-induced reduction of calcium deposition. Our results suggest that reduction of
miR-27a-3p
may contribute to the development of vascular calcification by de-repression of ATF3.
“…It was reported that EVL contained a CpG island in the promoter region, and the CpG island aberrant methylation inhibited miR-342 expression in human colorectal cancer, which was a transcription product of EVL intron [42]. Another article confirmed the effect of miR-342-3p in osteogenic differentiation and explored the regulation mechanism between miR-342-3p and DNA methylation of its hosting gene EVL [37]. They found hypomethylation in the promoter of EVL promoted the miR-342-3p expression in osteogenic differentiation, Li et al [35] miRNA miR-29b MiR-29b targeted DNMT1 and led to the methylation modification in the Notch1 promoter, which affected the Notch signaling pathway and regulated the osteogenic differentiation in BMSCs.…”
Section: Osteogenic Differentiationmentioning
confidence: 99%
“…Han et al [37] lncRNA H19 H19 has a strong osteogenic effect via the NOTCH1 pathway, and hypomethylation in the H19 promoter was associated with the high expression of H19.…”
Bone diseases such as osteoarthritis, osteoporosis, and bone tumor present a severe public health problem. Osteogenic differentiation is a complex process associated with the differentiation of different cells, which could regulate transcription factors, cytokines, many signaling pathways, noncoding RNAs (ncRNAs), and epigenetic modulation. DNA methylation is a kind of stable epigenetic alterations in CpG islands without DNA sequence changes and is involved in cancer and other diseases, including bone development and homeostasis. ncRNAs can perform their crucial biological functions at the RNA level, and many findings have demonstrated essential functions of ncRNAs in osteogenic differentiation. In this review, we highlight current researches in DNA methylation of two relevant ncRNAs, including microRNAs and long noncoding RNAs, in the initiation and progression of osteogenesis and bone diseases.
“…2018), miR-342-3p (Y. Han et al, 2018), miR-451a (Karvande et al, 2018), and miR-874 (Lin et al, 2018). In addition, it has recently been reported that miR-21 and miR-218 play a physiological role in osteocytes, which are differentiated OBs embedded in the bone matrix (Davis et al, 2017).…”
Section: Function Of Mirnas In Bone Physiologymentioning
Bone metastases are frequent complications in patients with advanced cancer, which can be fatal or may rapidly impede the quality of life of patients. Current treatments for patients with bone metastases are palliative. Therefore, a better understanding of the molecular mechanisms that precede the overt development of skeletal lesions could lead to better therapeutic interventions. In this review, we present evidence that non-coding RNAs (ncRNAs) such as long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and circular RNAs (circRNAs) are emerging as master regulators of bone metastasis formation. We highlight potential opportunities for the therapeutic targeting of ncRNAs. Furthermore, we discuss the possibility that ncRNAs may be used as biomarkers in the context of bone metastases, which might provide insight for improving the response to current bone-targeting therapies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.